FDG PET/CT in the management of colorectal and anal cancers

Ankit Agarwa, Charles Marcus, Jennifer Xiao, Prachi Nene, Lisa A. Kachnic, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.

Original languageEnglish (US)
Pages (from-to)1109-1119
Number of pages11
JournalAmerican Journal of Roentgenology
Volume203
Issue number5
DOIs
StatePublished - Nov 1 2014

Fingerprint

Anus Neoplasms
Colorectal Neoplasms
Radiotherapy
Therapeutics

Keywords

  • Anal cancer
  • Colorectal cancer
  • PET/CT
  • Radiation therapy planning
  • Therapy assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Agarwa, A., Marcus, C., Xiao, J., Nene, P., Kachnic, L. A., & Subramaniam, R. M. (2014). FDG PET/CT in the management of colorectal and anal cancers. American Journal of Roentgenology, 203(5), 1109-1119. https://doi.org/10.2214/AJR.13.12256

FDG PET/CT in the management of colorectal and anal cancers. / Agarwa, Ankit; Marcus, Charles; Xiao, Jennifer; Nene, Prachi; Kachnic, Lisa A.; Subramaniam, Rathan M.

In: American Journal of Roentgenology, Vol. 203, No. 5, 01.11.2014, p. 1109-1119.

Research output: Contribution to journalArticle

Agarwa, A, Marcus, C, Xiao, J, Nene, P, Kachnic, LA & Subramaniam, RM 2014, 'FDG PET/CT in the management of colorectal and anal cancers', American Journal of Roentgenology, vol. 203, no. 5, pp. 1109-1119. https://doi.org/10.2214/AJR.13.12256
Agarwa A, Marcus C, Xiao J, Nene P, Kachnic LA, Subramaniam RM. FDG PET/CT in the management of colorectal and anal cancers. American Journal of Roentgenology. 2014 Nov 1;203(5):1109-1119. https://doi.org/10.2214/AJR.13.12256
Agarwa, Ankit ; Marcus, Charles ; Xiao, Jennifer ; Nene, Prachi ; Kachnic, Lisa A. ; Subramaniam, Rathan M. / FDG PET/CT in the management of colorectal and anal cancers. In: American Journal of Roentgenology. 2014 ; Vol. 203, No. 5. pp. 1109-1119.
@article{65829b5c8e49461dad58ea533e0d1176,
title = "FDG PET/CT in the management of colorectal and anal cancers",
abstract = "OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.",
keywords = "Anal cancer, Colorectal cancer, PET/CT, Radiation therapy planning, Therapy assessment",
author = "Ankit Agarwa and Charles Marcus and Jennifer Xiao and Prachi Nene and Kachnic, {Lisa A.} and Subramaniam, {Rathan M.}",
year = "2014",
month = "11",
day = "1",
doi = "10.2214/AJR.13.12256",
language = "English (US)",
volume = "203",
pages = "1109--1119",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "5",

}

TY - JOUR

T1 - FDG PET/CT in the management of colorectal and anal cancers

AU - Agarwa, Ankit

AU - Marcus, Charles

AU - Xiao, Jennifer

AU - Nene, Prachi

AU - Kachnic, Lisa A.

AU - Subramaniam, Rathan M.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.

AB - OBJECTIVE. CT remains the imaging modality of choice in the diagnosis of colorectal cancer (CRC) and anal cancer. However, advances in imaging have expanded the role of MRI and PET/CT. This article focuses on the evolving role of FDG PET/CT in the diagnosis, radiation therapy planning, therapy assessment, and posttherapy monitoring of CRC and anal cancer. CONCLUSION. FDG PET/CT is a valuable imaging modality that impacts the clinical management of patients with CRC and those with anal cancer.

KW - Anal cancer

KW - Colorectal cancer

KW - PET/CT

KW - Radiation therapy planning

KW - Therapy assessment

UR - http://www.scopus.com/inward/record.url?scp=84924924561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924924561&partnerID=8YFLogxK

U2 - 10.2214/AJR.13.12256

DO - 10.2214/AJR.13.12256

M3 - Article

C2 - 25341152

AN - SCOPUS:84924924561

VL - 203

SP - 1109

EP - 1119

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 5

ER -